ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | -89.2% | 300 | -86.4% | 0.00% | – |
| Q3 2018 | $37,000 | -2.6% | 2,200 | -8.3% | 0.00% | – |
| Q2 2018 | $38,000 | +31.0% | 2,400 | -4.0% | 0.00% | – |
| Q4 2017 | $29,000 | -94.0% | 2,500 | -94.1% | 0.00% | -100.0% |
| Q2 2017 | $486,000 | -40.9% | 42,416 | +7.2% | 0.00% | -50.0% |
| Q1 2017 | $823,000 | +146.4% | 39,579 | +145.2% | 0.00% | +100.0% |
| Q4 2016 | $334,000 | – | 16,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |